Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Stratification of Patients With Non-Visible Hematuria - A Prospective Validation Study Using a Urine Marker-Based Assessment (Xpert® Bladder Cancer Detect)

NCT07307300 is registered in ClinicalTrials.gov with Christian Bolenz as lead sponsor.

NCT NCT07307300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07307300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Stratification of Patients With Non-Visible Hematuria - A Prospective Validation Study Using a Urine Marker-Based Assessment (Xpert® Bladder Cancer Detect)
Lead sponsor
Christian Bolenz
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
June 30, 2028
Enrollment
1,475 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematuria